<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease</dc:title><dc:creator>Schoser,	Benedikt	(Avtor)
	</dc:creator><dc:creator>Kishnani,	Priya S.	(Avtor)
	</dc:creator><dc:creator>Bratkovic,	Drago	(Avtor)
	</dc:creator><dc:creator>Byrne,	Barry J.	(Avtor)
	</dc:creator><dc:creator>Claeys,	Kristl G.	(Avtor)
	</dc:creator><dc:creator>Diaz-Manera,	Jordi	(Avtor)
	</dc:creator><dc:creator>Laforet,	Pascal	(Avtor)
	</dc:creator><dc:creator>Roberts,	Mark	(Avtor)
	</dc:creator><dc:creator>Toscano,	Antonio	(Avtor)
	</dc:creator><dc:creator>Van der Ploeg,	Ans. T.	(Avtor)
	</dc:creator><dc:creator>Koritnik,	Blaž	(Sodelavec pri raziskavi)
	</dc:creator><dc:subject>glycogen storage disease type II</dc:subject><dc:subject>alpha glucosidase</dc:subject><dc:subject>myozyme</dc:subject><dc:subject>n-butyldeoxynojirimycin</dc:subject><dc:subject>Lysosomal storage disorders</dc:subject><dc:date>2024</dc:date><dc:date>2026-06-12 09:47:36</dc:date><dc:type>Neznano</dc:type><dc:identifier>30030</dc:identifier><dc:identifier>UDK: 61</dc:identifier><dc:identifier>ISSN pri članku: 1432-1459</dc:identifier><dc:identifier>DOI: 10.1007/s00415-024-12236-0</dc:identifier><dc:identifier>COBISS_ID: 230906883</dc:identifier><dc:language>sl</dc:language></metadata>
